1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
-
  1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch

Puncture Robotic

Have updates for this profile?  Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Year established

2019

Location

Shanghai China

Primary Industry

Medical Devices & Equipment

About

Established in 2019 and based in Shanghai, China, Puncture Robotic operates as a developer of fusion image-guided surgical robots that specialize in the design and development of medical puncture robots. The research and development of Puncture Robotic was incubated in Jiangsu Hagong Intelligent Robot. It has partnerships with Huashan Hospital, China-Japan Friendship Hospital, Ruijin Hospital, GE HealthCare, and KUKA Med. In addition, it established the Artificial Intelligence Hair Innovation Center in June 2023 in conjunction with the Shanghai Hair Medicine Engineering Technology Research Center, Suzhou Collaborative Innovation Medical Robotics Research Institute, the National Center for Integrative Medicine, the Artificial Intelligence Research Institute of Harbin Institute of Technology, and Tree of Life Medical. In September 2024, Puncture Robotic closed a pre-series B+ funding.     The company's main business is the development of fusion image-guided surgical robots. Its self-developed products include hair transplant robots and surgical robotic puncture navigation systems. The products manufactured by Puncture Robotic can be used in clinical applications such as vascular access puncture applications, tumour interventions, biopsies, anaesthesia, and medical aesthetics. The company’s revenue is generated by developing and providing medical puncture robots. The company will use the pre-series B+ funding to promote the implementation of hair loss diagnosis and treatment solutions and the market promotion of hair transplant robots.
Current Investors
Lenovo Venture Capital, GSR United Capital, Jolmo Capital

Request a demo to show more

Primary Industry
Medical Devices & Equipment
Sub Industries
Healthcare IT, Diagnostic Equipment, Surgical Devices
Website
www.pangce.com.cn
Verticals
Artificial Intelligence, HealthTech, Robotics
Company Stage
Series A
Total Amount Raised
Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.